By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novoclem 



Durham  North Carolina    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Novoclem Therapeutics was created to develop nitric oxide solutions for cystic fibrosis and other respiratory diseases. It is initially focused on developing a treatment for severe bacterial lung infections in CF patients. The technology is effective against both antibiotic-resistant Pseudomonas aeruginosa, which is present in the lungs of approximately 60 percent of patients with CF, and Mycobacterium abscessus, a growing threat to CF patients. The company anticipates submitting an Investigational New Drug application and initiating First in Human clinical trials in early 2018.

LEADERSHIP:

CEO: Anne Whitaker


Key Statistics


Email:
Ownership: Private

Web Site: Novoclem
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->